Artificial intelligence can help radiologists detect breast cancer sooner when it is more treatable – but what does that mean for the breast imaging industry? Nico Karssemeijer, Chief Science Officer and Co-Founder of ScreenPoint Medical, joins Impact AI podcast to discuss how his team is revolutionizing breast cancer screening through cutting-edge AI.
With over 40 years of experience in medical imaging, Nico explains how ScreenPoint’s technology supports radiologists by analyzing mammograms at speed and scale, pinpointing risk and opportunity, and improving accuracy over time.
The episode delves into the essentials of building reliable medical AI: managing diverse datasets, addressing device-specific differences, and ensuring rigorous clinical validation.
Explore how AI is being implemented in real-world healthcare settings across the globe and what it takes to build a successful, trusted, and AI-first company. Listen now:
